Advancing Therapeutic Strategies for Relapsed/Refractory Acute Lymphoblastic Leukemia

1,084
Total downloads
4,749
Total views and downloads

Articles

ORIGINAL RESEARCH

Accepted on 12 Sep 2025

Efficacy and safety of the third-generation tyrosine kinase inhibitor Olverembatinib in relapsed and persistent minimal residual disease positive Philadelphia chromosome-positive Acute Lymphoblastic Leukemia patients

Xinwen Jiang
Minran Zhou
Qingli Ji
Xiaoqing Li
Sai Ma
Chunyan Chen

doi 10.3389/fmed.2025.1662512

280 views

ORIGINAL RESEARCH

Published on 08 Sep 2025

Serum proteome profiling identified thrombospondin-1 and lactoferrin as biomarkers of relapsed multiple myeloma

Xiaoxiao Wu
Jianying Guo
Haiteng Deng
Wenming Chen

doi 10.3389/fmed.2025.1640245

559 views

CASE REPORT

Published on 14 Jan 2025

Venetoclax in combination with chidamide and azacitidine for the treatment of relapsed/refractory B-cell acute lymphoblastic leukemia with the MLL-AF4 gene: a case report and literature review

Xuelian Jin
Zhigang Liu
Yu Wu
Jie Ji

doi 10.3389/fimmu.2024.1475974

2,110 views
3 citations

Share on

Frontiers in Medicine

Frontiers in Medicine

Hematology

Impact

4,749Topic views
2,741Article views
1,084Article downloads